BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12432941)

  • 1. Endocannabinoid hydrolases.
    Ueda N
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():521-34. PubMed ID: 12432941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anandamide amidohydrolase (fatty acid amide hydrolase).
    Ueda N; Yamamoto S
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):19-28. PubMed ID: 10785539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fatty acid amide hydrolase (FAAH).
    Deutsch DG; Ueda N; Yamamoto S
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):201-10. PubMed ID: 12052036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
    J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.
    Vandevoorde S; Lambert DM
    Curr Pharm Des; 2005; 11(20):2647-68. PubMed ID: 16101463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying the catalytic roles of conserved residues in the amidase signature family.
    Patricelli MP; Cravatt BF
    J Biol Chem; 2000 Jun; 275(25):19177-84. PubMed ID: 10764768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Tsuboi K; Takezaki N; Ueda N
    Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second fatty acid amide hydrolase with variable distribution among placental mammals.
    Wei BQ; Mikkelsen TS; McKinney MK; Lander ES; Cravatt BF
    J Biol Chem; 2006 Dec; 281(48):36569-78. PubMed ID: 17015445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
    Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
    J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fatty acid amide hydrolase (FAAH).
    Ueda N; Puffenbarger RA; Yamamoto S; Deutsch DG
    Chem Phys Lipids; 2000 Nov; 108(1-2):107-21. PubMed ID: 11106785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.
    Ueda N; Okamoto Y; Tsuboi K
    Curr Med Chem; 2005; 12(12):1413-22. PubMed ID: 15974992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties.
    Patricelli MP; Lovato MA; Cravatt BF
    Biochemistry; 1999 Aug; 38(31):9804-12. PubMed ID: 10433686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis thaliana.
    Shrestha R; Dixon RA; Chapman KD
    J Biol Chem; 2003 Sep; 278(37):34990-7. PubMed ID: 12824167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
    Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Ueda N; Tsuboi K; Uyama T
    Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Saario S; Nevalainen T
    Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and recombinant expression of anandamide hydrolyzing enzyme from Dictyostelium discoideum.
    Neelamegan D; Schoenhofen IC; Richards JC; Cox AD
    BMC Microbiol; 2012 Jun; 12():124. PubMed ID: 22730904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.